All News #Library
Biotech
TASK Fund Covers 2/3 of Sen-Jam Pharma`s SJP-001 Trial Costs
11 Dec 2025 //
PR NEWSWIRE
Sen-Jam Pharma Appoints Rute Fernandes As Executive Advisor
09 Dec 2025 //
PR NEWSWIRE
Sen-Jam`s SJP-001 Advances FDA Hangover Prevention Therapy
25 Jul 2025 //
PR NEWSWIRE
Sen-Jam Reports Early Success In Respiratory Treatment Trials
15 Jan 2025 //
PR NEWSWIRE
Sen-Jam Completes SJP-002C Trial For Respiratory Infections, COVID-19
22 May 2024 //
PR NEWSWIRE

Market Place
Sourcing Support